Notably, USP1 downregulation enhances the sensitivity of CRC cells to chemotherapeutic agents [7], and USP21 is shown to accelerate metastasis of CRC via mediating deubiquitination of fos-related-antigen-1 [8]. The gene discussed is USP21; the disease is colorectal carcinoma.